From master cell bank production and expansion through to manufacture, we support you with the latest technologies from a state-of-the-art facility dedicated to the aseptic production of lentiviral vectors, helping you deliver life-changing therapeutics to patients.
Our lentivirus expertise highlights the expansive knowledge and technical talent of our team. This, combined with expertise in transient infection and available and scalable capacity, ensures we can accelerate your journey from bench-to-clinic and maintain reliable supply throughout.
Ensuring high product throughput and efficiency, our production platform utilizes single-use technology and optimized closed and semi-automated processes for viral vector production to deliver larger batches with greater consistency and reliability.
We deliver a full suite of complementary process development capabilities to support cGMP and commercial readiness, upstream and downstream process improvements, research-grade and preclinical vector production, and analytical assay development and validation from the site.
Analytical testing services, including Recombinant Competent Lentivirus (RCL) testing, vector stability testing, and safety and sterility testing, are also available.
Scalable and Consistent Manufacturing
We can initiate and maintain reliable supply for your early phase clinical trials and beyond, delivering high-quality, cost-effective and precise GMP master cell bank retroviral vector production and host cell expansion via producer cell lines.
We support you in developing robust, scalable, and efficient processes to help you realize the potential of your therapy.Read more
Leverage our world-class partnerships, streamline your production, and advance your cell therapy to trial and beyond.Read more